SAND-5

N/A

Report date: 2025/01/26 17:57:44

Base Information

Drug NameSAND-5

Drug Alias Namecomplement C5 minibody (ADIENNE)MubodinaSAND-5

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists

TargetsC5a anaphylatoxin chemotactic receptor

Therapy Area/IndicationsHemolytic-Uremic SyndromeGlomerulonephritis, Membranoproliferative

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesEuropeItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesADIENNE Pharma & Biotech SA

China Registration ClassN/A

Develop Information

Active CompaniesADIENNE Pharma & Biotech SA

Inactive CompaniesN/A

Active IndicationsHemolytic-Uremic SyndromeGlomerulonephritis, Membranoproliferative

Inactive IndicationsN/A

Other Information

ATC CodeN/A